UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 608

Sortiert nach

Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues

PLoS biology, 2022-10, Vol.20 (10), p.e3001826

2022

Volltextzugriff (PDF)

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

PLoS pathogens, 2017-03, Vol.13 (3), p.e1006283

2017

Volltextzugriff (PDF)

Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy

PLoS pathogens, 2014-03, Vol.10 (3), p.e1004010

2014

Volltextzugriff (PDF)

Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses

Retrovirology, 2011-11, Vol.8 (1), p.90-90, Article 90

2011

Volltextzugriff (PDF)

50th anniversary of the discovery of reverse transcriptase

Molecular biology of the cell, 2021-01, Vol.32 (2), p.91-97

2021

Volltextzugriff (PDF)

discovery of HTLV-1, the first pathogenic human retrovirus

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (51), p.15525-15529

Coffin, John M

2015

Volltextzugriff (PDF)

Effects of retroviruses on host genome function

Annual review of genetics, 2008-01, Vol.42 (1), p.709-732

2008

Volltextzugriff (PDF)

Nomenclature for endogenous retrovirus (ERV) loci

Retrovirology, 2018-08, Vol.15 (1), p.59-59, Article 59

2018

Volltextzugriff (PDF)

What Integration Sites Tell Us about HIV Persistence

Cell host & microbe, 2016-05, Vol.19 (5), p.588-598

2016

Volltextzugriff (PDF)

Discovery of unfixed endogenous retrovirus insertions in diverse human populations

Proceedings of the National Academy of Sciences - PNAS, 2016-04, Vol.113 (16), p.E2326-E2334

2016

Volltextzugriff (PDF)

Virions at the gates: receptors and the host-virus arms race

PLoS biology, 2013-05, Vol.11 (5), p.e1001574-e1001574

Coffin, John M

2013

Volltextzugriff (PDF)

Quantification of HIV-1 latency reversal in resting CD4⁺ T cells from patients on suppressive antiretroviral therapy

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (19), p.7078-7083

2014

Volltextzugriff (PDF)

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

Proceedings of the National Academy of Sciences - PNAS, 2017-05, Vol.114 (18), p.E3659-E3668

2017

Volltextzugriff (PDF)

Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy

PLoS pathogens, 2021-04, Vol.17 (4), p.e1009141-e1009141

2021

Volltextzugriff (PDF)

Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

The Journal of infectious diseases, 2017-06, Vol.215 (11), p.1725-1733

2017

Volltextzugriff (PDF)

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

PLoS medicine, 2010-08, Vol.7 (8), p.e1000321

2010

Volltextzugriff (PDF)

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection

PloS one, 2010-02, Vol.5 (2), p.e9390-e9390

2010

Volltextzugriff (PDF)

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

The Journal of clinical investigation, 2019-11, Vol.129 (11), p.4629-4642

2019

Volltextzugriff (PDF)

Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule

PLoS pathogens, 2013, Vol.9 (6), p.e1003432-e1003432

2013

Volltextzugriff (PDF)

Endogenous non-retroviral RNA virus elements in mammalian genomes

Nature (London), 2010-01, Vol.463 (7277), p.84-87

2010

Volltextzugriff (PDF)

HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production

Journal of virology, 2014-10, Vol.88 (19), p.11108-11120

2014

Volltextzugriff (PDF)

Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000367-e1000367

2009

Volltextzugriff (PDF)

Clonal Expansion of Infected CD4+ T Cells in People Living with HIV

Viruses, 2021-10, Vol.13 (10), p.2078

2021

Volltextzugriff (PDF)

Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans

PLoS pathogens, 2019-07, Vol.15 (7), p.e1007869

2019

Volltextzugriff (PDF)

Low-Level Viremia Persists for at Least 7 Years in Patients on Suppressive Antiretroviral Therapy

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (10), p.3879-3884

2008

Volltextzugriff (PDF)

1 – 25 von 608

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(549)
Mit Volltextzugriff
(561)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(373)
Life Sciences & Biomedicine
(267)
Humans
(226)
Animals
(136)
Virology
(120)
Biological And Medical Sciences
(101)
Viruses
(99)
Hiv
(91)
Multidisciplinary Sciences
(91)
Science & Technology - Other Topics
(91)
Male
(86)
Human Immunodeficiency Virus
(84)
Female
(81)
Microbiology
(81)
Fundamental And Applied Biological Sciences. Psychology
(62)
Mutation
(62)
Mice
(59)
Base Sequence
(58)
Infections
(58)
Biological Sciences
(57)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy

Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses

50th anniversary of the discovery of reverse transcriptase

discovery of HTLV-1, the first pathogenic human retrovirus

Effects of retroviruses on host genome function

Nomenclature for endogenous retrovirus (ERV) loci

What Integration Sites Tell Us about HIV Persistence

Discovery of unfixed endogenous retrovirus insertions in diverse human populations

Virions at the gates: receptors and the host-virus arms race

Quantification of HIV-1 latency reversal in resting CD4⁺ T cells from patients on suppressive antiretroviral therapy

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy

Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule

Endogenous non-retroviral RNA virus elements in mammalian genomes

HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production

Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance

Clonal Expansion of Infected CD4+ T Cells in People Living with HIV

Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans

Low-Level Viremia Persists for at Least 7 Years in Patients on Suppressive Antiretroviral Therapy

Suchergebnisse filtern